Docusate Calcium Softgel Capsules, 240 mg, OTC, packaged and labeled to contain Docusate Sodium 240mg, Repackaged By: Shamrock Medical Solutions Lewis Center, Ohio, Mfg: Major Pharmaceuticals, Livonia, MI NDC 00904-5779-60
Published July 30, 2014 · Recall initiated: September 27, 2011
Summary
FDA records drug Class II recall D-1451-2014, published July 30, 2014 and initiated September 27, 2011. Recalling firm: Shamrock Medical Solutions Group LLC; Status: Terminated; Reported quantity: 99/240 mg softgel caps; Lot: Lot #: 002H79, Use By: 06/19/2013, NDC: 00904-5779-60. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label Mix up; product labeled to contain Docusate Sodium 240mg instead of Docusate Calcium 240mg
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Shamrock Medical Solutions Group LLC
- Distributor
- Product was shipped to the following states: CO, MA, OH, TX & WY.
- Lot
- Lot #: 002H79, Use By: 06/19/2013, NDC: 00904-5779-60
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAmetFORMIN ER Tablets, 500 mg, Rx, Packaged and labeled as metFORMIN Immediate Release (IR), Repackaged By:July 30, 2014
- FDAOxycodone HCl Oral Concentrate, 20 mg/mL, Rx (C-II) Packaged and labeled as Morphine Sulfate 20 mg/mL, Mfg:July 30, 2014
- FDATaztia XT (Diltiazem HCl) Capsules, 120 mg, Rx, Packaged and labeled as Thiamine. Re-Packaged By: ShamrockJuly 30, 2014
- FDASulfamethoxazole and Trimethoprim Tablets, 800 mg/160 mg, DOUBLE STRENGTH, Rx, packaged and labeled to containJuly 30, 2014
- FDADENBLAN Anticavity Fluoride Toothpaste, Whitening formula, sodium monofluorophosphate 0.76%, 2.6 oz/75 mLJuly 30, 2014
- FDAPramipexole Dihydrochloride Tablets, 0.5 mg, Rx, packaged and labeled to contain Nebivolol tablets, RepackagedJuly 30, 2014
Questions about this recall
Was Docusate Calcium Softgel Capsules, 240 mg, OTC, packaged and labeled to contain Docusate Sodium 240mg, Repackaged By: Shamrock Medical Solutions Lewis Center, Ohio, Mfg: Major Pharmaceuticals, Livonia, MI NDC 00904-5779-60 recalled?
Yes. FDA published recall D-1451-2014 on July 30, 2014. Reported hazard: Labeling: Label Mix up; product labeled to contain Docusate Sodium 240mg instead of Docusate Calcium 240mg
What should I do if I have this product?
Voluntary: Firm initiated · Telephone